Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bluebird has a promising new update on its BCMA CAR-T for multiple myeloma, but is it still the leader?
Bluebird has a promising new update on its BCMA CAR-T for multiple myeloma, but is it still the leader?
Bluebird has a promising new update on its BCMA CAR-T for multiple myeloma, but is it still the leader?
Submitted by
admin
on June 5, 2017 - 12:10pm
Source:
Endpoints
News Tags:
Bluebird Bio
BCMA
CAR-T
Multiple Myeloma
ASCO 2017
bb2121
Celgene
Headline:
Bluebird has a promising new update on its BCMA CAR-T for multiple myeloma, but is it still the leader?
Do Not Allow Advertisers to Use My Personal information
